P2Y12 Inhibitors Beat Aspirin in Heart Attack Defense
P2Y12 Inhibitors Linked to Improved Outcomes in Coronary Artery Disease For individuals managing coronary artery disease, the choice of medication can significantly impact their long-term […]
Tag: Coronary Artery Disease
Riliprubart CAD therapy possible once per quarter: Research
Riliprubart: A Promising Treatment for Coronary Artery Disease with Convenient Dosing Exciting news for individuals managing Coronary Artery Disease (CAD)! A recent study suggests that […]
Heart Health After Long COVID and Acute COVID Cases
Severe COVID-19 Identified as a New Risk Factor for Coronary Artery Disease Cardiovascular health is a widespread concern, and recent findings suggest a new element […]
